- McBride first joined AmorChem in 2012
- Based in Montreal, AmorChem was launched in 2011
- The firm has financed over 30 university projects and started up several biotechnology companies from the fruits of this research
AmorChem, a Canadian early-stage venture capital firm focused on life sciences, has promoted Kevin McBride to general partner.
McBride first joined AmorChem in 2012.
“Kevin brings a comprehensive understanding of fundamental and translational research which is a key component in setting portfolio strategy and lends him a credibility crucial to the attraction of partners, both financial and pharmaceutical,” said Ines Holzbaur, managing partner of AmorChem, in a statement. “It’s a pleasure to recognise the value of his work through this new title and function.”
Based in Montreal, AmorChem was launched in 2011 and today oversees more than C$85 million under management. The firm has financed over 30 university projects and started up several biotechnology companies from the fruits of this research.